Works matching IS 03065251 AND DT 2018 AND VI 84 AND IP 5

Results: 33

Issue highlights.

Published in:: 2018
Publication type:: Abstract

Pityriasis rosea‐like eruption associated with ondansetron use in pregnancy.

Published in:

2018

By:

Alame, Malak M.;
Chamsy, Dina J.;
Zaraket, Hassan

Publication type:

Case Study

Severe central sleep apnoea associated with nalmefene: a case report.

Published in:

2018

By:

Khouri, Charles;
Arbib, François;
Revol, Bruno;
Pepin, Jean‐Louis;
Tamisier, Renaud

Publication type:

Case Study

Three case reports of involuntary muscular movements as adverse reactions to sacubitril/valsartan.

Published in:

2018

By:

Bejan‐Angoulvant, Theodora;
Genet, Thibaud;
Vrignaud, Laura;
Angoulvant, Denis;
Fauchier, Laurent

Publication type:

Case Study

Acenocoumarol as an alternative anticoagulant in a patient with warfarin‐related nephropathy.

Published in:

2018

By:

Behera, Sapan Kumar;
Xavier, Alphienes Stanley;
Selvarajan, Sandhiya;
Munuswamy, Hemachandren;
Haridasan, Satish;
Srinivas, Bheemanathi Hanuman

Publication type:

Case Study

Comparative cardiovascular safety of nonsteroidal anti‐inflammatory drugs in patients with hypertension: a population‐based cohort study.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1045, doi. 10.1111/bcp.13537

By:

Dong, Yaa‐Hui;
Chang, Chia‐Hsuin;
Wu, Li‐Chiu;
Hwang, Jing‐Shiang;
Toh, Sengwee

Publication type:

Article

Implications of intercorrelation between hepatic CYP3A4‐CYP2C8 enzymes for the evaluation of drug–drug interactions: a case study with repaglinide.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 972, doi. 10.1111/bcp.13533

By:

Doki, Kosuke;
Darwich, Adam S.;
Achour, Brahim;
Tornio, Aleksi;
Backman, Janne T.;
Rostami‐Hodjegan, Amin

Publication type:

Article

A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration‐resistant metastatic prostate cancer.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1064, doi. 10.1111/bcp.13532

By:

Benoist, Guillemette E.;
van der Doelen, Maarten J.;
ter Heine, Rob;
van Erp, Nielka P.;
Mehra, Niven

Publication type:

Article

Time‐to‐event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 944, doi. 10.1111/bcp.13530

By:

Nakamura, Mikiko;
Xu, Chao;
Diack, Cheikh;
Ohishi, Norihisa;
Lee, Ruey‐min;
Iida, Satofumi;
Kawanishi, Takehiko;
Ohtomo, Toshihiko;
Abou‐Alfa, Ghassan K.;
Chen, Ya‐Chi

Publication type:

Article

The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1013, doi. 10.1111/bcp.13524

By:

Tafuri, Giovanni;
Lucas, Inês;
Estevão, Steve;
Moseley, Jane;
d'Andon, Anne;
Bruehl, Hannah;
Gajraj, Elangovan;
Garcia, Sonia;
Hedberg, Niklas;
Massari, Marco;
Molina, Andrea;
Obach, Mercè;
Osipenko, Leeza;
Petavy, Frank;
Petschulies, Marco;
Pontes, Caridad;
Russo, Pierluigi;
Schiel, Anja;
Van de Casteele, Marc;
Zebedin‐Brandl, Eva‐Maria

Publication type:

Article

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 997, doi. 10.1111/bcp.13526

By:

Zhao, Wei;
Leroux, Stéphanie;
Biran, Valérie;
Jacqz‐Aigrain, Evelyne

Publication type:

Article

Reply to ‘Comment on “Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study” by Muanda et al.’.

Published in:

2018

By:

Muanda, Flory;
Sheehy, Odile;
Berard, Anick

Publication type:

Letter to the Editor

Glutathione‐PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first‐in‐human study.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1020, doi. 10.1111/bcp.13525

By:

Kanhai, K. M. S.;
Zuiker, R. G. J. A.;
Stavrakaki, I.;
Gladdines, W.;
Gaillard, P. J.;
Klaassen, E. S.;
Groeneveld, G. J.

Publication type:

Article

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 961, doi. 10.1111/bcp.13519

By:

Marra, Fiona;
Höner zu Siederdissen, Christoph;
Khoo, Saye;
Back, David;
Schlag, Michael;
Ouwerkerk‐Mahadevan, Sivi;
Bicer, Ceyhun;
Lonjon‐Domanec, Isabelle;
Jessner, Wolfgang;
Beumont‐Mauviel, Maria;
Kalmeijer, Ronald;
Cornberg, Markus

Publication type:

Article

Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 987, doi. 10.1111/bcp.13522

By:

Santoro, Ana Beatriz;
Botton, Mariana Rodrigues;
Struchiner, Claudio José;
Suarez‐Kurtz, Guilherme

Publication type:

Article

Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1006, doi. 10.1111/bcp.13521

By:

Andrew, Eden C.;
Curtis, Nigel;
Coghlan, Ben;
Cranswick, Noel;
Gwee, Amanda

Publication type:

Article

First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japanese healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 876, doi. 10.1111/bcp.13520

By:

Perera, Vidya;
Luettgen, Joseph M.;
Wang, Zhaoqing;
Frost, Charles E.;
Yones, Cynthia;
Russo, Cesare;
Lee, John;
Zhao, Yue;
LaCreta, Frank P.;
Ma, Xuewen;
Knabb, Robert M.;
Seiffert, Dietmar;
DeSouza, Mary;
Mugnier, Pierre;
Cirincione, Brenda;
Ueno, Takayo;
Frost, Robert J. A.

Publication type:

Article

Better characterization of vinflunine pharmacokinetics variability and exposure/toxicity relationship to improve its use: Analyses from 18 trials.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 900, doi. 10.1111/bcp.13518

By:

Schmitt, Antonin;
Nguyen, Laurent;
Zorza, Grégoire;
Ferré, Pierre;
Pétain, Aurélie

Publication type:

Article

Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 952, doi. 10.1111/bcp.13517

By:

Nomoto, Maiko;
Zamora, Cynthia A.;
Schuck, Edgar;
Boyd, Peter;
Chang, Min‐Kun;
Aluri, Jagadeesh;
Siu, Y. Amy;
Lai, W. George;
Yasuda, Sanae;
Ferry, Jim;
Rege, Bhaskar

Publication type:

Article

The impact of diuretic use and <italic>ABCG2</italic> genotype on the predictive performance of a published allopurinol dosing tool.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 937, doi. 10.1111/bcp.13516

By:

Wright, Daniel F. B.;
Dalbeth, Nicola;
Phipps‐Green, Amanda J.;
Merriman, Tony R.;
Barclay, Murray L.;
Drake, Jill;
Tan, Paul;
Horne, Anne;
Stamp, Lisa K.

Publication type:

Article

A systematic review of population pharmacokinetics of valproic acid.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 816, doi. 10.1111/bcp.13510

By:

Methaneethorn, Janthima

Publication type:

Article

Rhabdomyolysis after co‐administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1057, doi. 10.1111/bcp.13515

By:

Deljehier, Thomas;
Pariente, Antoine;
Miremont‐Salamé, Ghada;
Haramburu, Françoise;
Nguyen, Linh;
Rubin, Sébastien;
Rigothier, Claire;
Théophile, Hélène

Publication type:

Article

Discontinuities and disruptions in drug dosage guidelines for the paediatric population.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1029, doi. 10.1111/bcp.13511

By:

Chitty, Kate M.;
Chan, Bosco;
Pulanco, Camille L.;
Luu, Sonya;
Egunsola, Oluwaseun;
Buckley, Nicholas A.

Publication type:

Article

Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 846, doi. 10.1111/bcp.13514

By:

Falconer, Nazanin;
Barras, Michael;
Cottrell, Neil

Publication type:

Article

Dasatinib‐induced pulmonary arterial hypertension.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 835, doi. 10.1111/bcp.13508

By:

Özgür Yurttaş, Nurgül;
Eşkazan, Ahmet Emre

Publication type:

Article

Reversal of mecamylamine‐induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 888, doi. 10.1111/bcp.13507

By:

Alvarez‐Jimenez, Ricardo;
Hart, Ellen P.;
Prins, Samantha;
de Kam, Marieke;
van Gerven, Joop M. A.;
Cohen, Adam F.;
Groeneveld, Geert Jan

Publication type:

Article

Teicoplanin anaphylaxis associated with surgical prophylaxis.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1038, doi. 10.1111/bcp.13506

By:

Azamgarhi, Tariq;
Shah, Ashik;
Warren, Simon

Publication type:

Article

Effect of the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 926, doi. 10.1111/bcp.13505

By:

Ayalasomayajula, Surya;
Schuehly, Uwe;
Pal, Parasar;
Chen, Fabian;
Zhou, Wei;
Sunkara, Gangadhar;
Langenickel, Thomas H.

Publication type:

Article

Pharmacokinetic–pharmacodynamic modelling of neutrophil response to G‐CSF in healthy subjects and patients with chemotherapy‐induced neutropenia.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 911, doi. 10.1111/bcp.13504

By:

Melhem, Murad;
Delor, Isabelle;
Pérez‐Ruixo, Juan Jose;
Harrold, John;
Chow, Andrew;
Wu, Liviawati;
Jacqmin, Philippe

Publication type:

Article

Topical administration of regorafenib eye drops: phase I dose‐escalation study in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 865, doi. 10.1111/bcp.13502

By:

Zimmermann, Torsten;
Höchel, Joachim;
Becka, Michael;
Boettger, Michael K.;
Rohde, Beate;
Schug, Barbara;
Kunert, Kathleen S.;
Donath, Frank

Publication type:

Article

Comment on “Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study” by Muanda et al.

Published in:

2018

By:

Acar, Selin;
Erol‐Coskun, Hilal;
Kaplan, Yusuf Cem

Publication type:

Letter to the Editor

Opioids out of control.

Published in:

2018

By:

Floyd, Christopher N.;
Warren, John B.

Publication type:

Editorial

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 809, doi. 10.1111/bcp.13411
Publication type:: Article